Sichuan Huiyu Pharmaceutical Co Ltd Cash Flow Quality Index
Sichuan Huiyu Pharmaceutical Co Ltd cash flow quality index. Sichuan Huiyu Pharmaceutical Co Ltd (688553) has a Cash Flow Quality Index of 1.96x as of September 2025. Operating cash flow of CN¥58.54 Million exceeds net income of CN¥29.92 Million, indicating high earnings quality where cash backs reported profits. Explore Sichuan Huiyu Pharmaceutical Co Ltd (688553) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Sichuan Huiyu Pharmaceutical Co Ltd (2019–2024)
Cash flow quality index of Sichuan Huiyu Pharmaceutical Co Ltd from 2019 to 2024. Historical Cash Flow Quality Index for Sichuan Huiyu Pharmaceutical Co Ltd across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. See 688553 equity to assets ratio to measure how much of total assets are equity-financed.
Sichuan Huiyu Pharmaceutical Co Ltd Cash Flow Quality Index by Year (2019–2024)
Sichuan Huiyu Pharmaceutical Co Ltd cash flow quality index by year from 2019 to 2024. Year-by-year earnings quality comparison for Sichuan Huiyu Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see 688553 cash flow metrics.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.77x | CN¥242.96 Million | CN¥315.90 Million | ▲ +60.6% |
| 2023 | 0.48x | CN¥66.93 Million | CN¥139.79 Million | ▼ -38.6% |
| 2022 | 0.78x | CN¥194.06 Million | CN¥248.99 Million | ▼ -22.1% |
| 2021 | 1.00x | CN¥446.36 Million | CN¥445.86 Million | ▼ -11.8% |
| 2020 | 1.13x | CN¥387.95 Million | CN¥341.82 Million | ▼ -38.5% |
| 2019 | 1.84x | CN¥326.22 Million | CN¥176.91 Million | — |